Search research articles
Contact Us
Filters
Showing results (131-140 of 177) with videos related to
Page
of 18
Sort By:
Journal of Medical Virology
|
October 21, 2025
The Clinical Presentations of Patients With COVID-19 in the Omicron Era: Missed Opportunities in the Antiviral Treatment of SARS-CoV-2 Infections
G Bartolucci, E Garro, M Mussa, et al.
Acta Neurologica
|
February 1, 1990
AIDS--associated predominantly sensory neuropathy. The role of herpes viruses
S Ferrari, B Bonetti, S Monaco, et al.
Journal of Neurovirology
|
August 7, 2015
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients
A Calcagno, C Atzori, A Romito, et al.
Journal of Neurovirology
|
June 29, 2014
Prevalence and predictors of blood-brain barrier damage in the HAART era
A Calcagno, M C Alberione, A Romito, et al.
Infection
|
November 4, 2011
The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria
F G De Rosa, N Pagani, L Fossati, et al.
European Review for Medical and Pharmacological Sciences
|
November 8, 2018
Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus
V Di Marco, A Alberti, G Angarano, et al.
Antiviral Research
|
May 28, 2014
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients
A Calcagno, L Marinaro, S Nozza, et al.
The Journal of Infection
|
March 14, 2000
Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy
G Di Perri, S Vento, R Mazzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
June 9, 2022
Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV
M Barale, M Massano, F Bioletto, et al.
HIV Clinical Trials
|
March 11, 2011
Maraviroc can improve lipid profiles in dyslipidemic patients with HIV: results from the MERIT trial
A MacInnes, A Lazzarin, G Di Perri, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 177) with videos related to
Sort By:
Page
of 18
Journal of Medical Virology
|
October 21, 2025
The Clinical Presentations of Patients With COVID-19 in the Omicron Era: Missed Opportunities in the Antiviral Treatment of SARS-CoV-2 Infections
G Bartolucci, E Garro, M Mussa, et al.
Acta Neurologica
|
February 1, 1990
AIDS--associated predominantly sensory neuropathy. The role of herpes viruses
S Ferrari, B Bonetti, S Monaco, et al.
Journal of Neurovirology
|
August 7, 2015
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients
A Calcagno, C Atzori, A Romito, et al.
Journal of Neurovirology
|
June 29, 2014
Prevalence and predictors of blood-brain barrier damage in the HAART era
A Calcagno, M C Alberione, A Romito, et al.
Infection
|
November 4, 2011
The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria
F G De Rosa, N Pagani, L Fossati, et al.
European Review for Medical and Pharmacological Sciences
|
November 8, 2018
Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus
V Di Marco, A Alberti, G Angarano, et al.
Antiviral Research
|
May 28, 2014
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients
A Calcagno, L Marinaro, S Nozza, et al.
The Journal of Infection
|
March 14, 2000
Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy
G Di Perri, S Vento, R Mazzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
June 9, 2022
Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV
M Barale, M Massano, F Bioletto, et al.
HIV Clinical Trials
|
March 11, 2011
Maraviroc can improve lipid profiles in dyslipidemic patients with HIV: results from the MERIT trial
A MacInnes, A Lazzarin, G Di Perri, et al.
Page
of 18